Supporting the health and wellbeing of children and young adults living with HIV

Members Area Donate

Supporting the health and wellbeing of children and young adults living with HIV

Current publications relating to paediatric HIV can also be found on the ISOSS and PENTA-ID websites.

Many research papers relating to paediatric HIV pre – 2021 are listed on the CHIPS website publications area.

Papers that may be of interest

Incidence of non-AIDS defining comorbidities among young adults with perinatally-acquired HIV in North America
Haw, Nel Jason L.a; Lesko, Catherine R.a, et al. AIDS. March 2024.
Infant feeding: emerging concepts to prevent HIV transmission.
Bamford A, Foster C, Lyall H et al. Curr Opin Infect Dis. Feb 2024.
Beliefs about antiretroviral therapy and their association with adherence in young people living with perinatal HIV in England: a cross-sectional analysis.
White I, Judd A, Castro H et al. Adolescents and Adults Living with Perinatal HIV (AALPHI) Steering Committee. AIDS Care. 2024.
Effectiveness and Safety of Direct-acting Antivirals for Treatment of Adolescents With HCV/HIV Coinfection: Real-world Data From Europe.
Malik F, Crichton S, Plotnikova Y et al. Pediatr Infect Dis J. 2024.
Psychological and Behavioural Within-participant Predictors of Adherence to Oral HIV Pre-Exposure Prophylaxis (PrEP).
Taylor A, Hayes R, Nwokolo N et al. AIDS Behav. 2024.
HIV-1 reservoir size after neonatal antiretroviral therapy and the potential to evaluate antiretroviral-therapy-free remission.
Persaud D, Bryson Y, Nelson BS, et al. Lancet HIV. Dec 2023.
Population Pharmacokinetic Modeling of Dolutegravir to Optimize Pediatric Dosing in HIV-1-Infected Infants, Children, and Adolescents.
Chandasana, Hardik et al. Clinical pharmacokinetics, 21 Aug. 2023.
Neuropsychiatric manifestations and sleep disturbances with dolutegravir-based antiretroviral therapy versus standard of care in children and adolescents: a secondary analysis of the ODYSSEY trial.
Turkova, Anna et al. The Lancet. Child & adolescent health. 7 Aug. 2023
Bone mineral density among children living with HIV failing first-line anti-retroviral therapy in Uganda: A sub-study of the CHAPAS-4 trial.
Natukunda, Eva et al. PloS one vol. 18,7 e0288877. 20 Jul. 2023.
Inadequate Lopinavir Concentrations With Modified 8-hourly Lopinavir/Ritonavir 4:1 Dosing During Rifampicin-based Tuberculosis Treatment in Children Living With HIV.
Chabala, Chishala et al.The Pediatric infectious disease journal. 20 Jul. 2023.
Incidence and severity of SARS-CoV-2 infection in children and young people with HIV in Europe.
The European Pregnancy and Paediatric Infections Cohort Collaboration (EPPICC) study group. AIDS (London, England) vol. 37,10 (2023)
Predictors of participant retention in a community-based HIV prevention cohort: perspectives from the HPTN 071 (PopART) study.
Bell-Mandla, Nomtha et al. Trials vol. 24,1 434. 27 Jun. 2023.

Support our work

Donations to Chiva are used to directly support our work with children and young people living with HIV and their families. Chiva is solely funded through donations, grants and membership income and receives no statutory funding.

Donate